Studies have elucidated heightened pseudohypoxic signaling in hereditary renal cell carcinoma, giving rise to the upregulation of downstream signaling molecules such as glucose transporter 1 and vascular endothelial growth factor (VEGF), thereby fostering augmented energy metabolism and proliferative capacity in tumor cells (26). This evidence concerns the gene VEGFA and hereditary renal cell carcinoma.